HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Acute organophosphate poisoning after disulfoton ingestion.

Abstract
A 75-year-old woman attempted suicide by ingesting a large quantity of granular Di-Syston which is an organophosphate insecticide containing 5% disulfoton (ethylthiometon). On admission, the total plasma phosphorodithioate sulfone concentration (disulfoton and its metabolites, phosphorodithioate sulfoxide and its sulfone) determined by gas chromatography was 1095 ng/mL. After gastric lavage, the concentration gradually decreased to 505 ng/mL. However, it began to increase again 20 h after admission and reached the peak concentration (1322 ng/mL) at 56 h. It was concluded that the secondary elevation of the plasma concentration was due to the prolonged absorption of the organophosphate from the residual granules in the stomach, despite the early gastric lavage. Pralidoxime iodide administration temporarily restored erythrocyte cholinesterase activity to almost normal and inhibited the excessive, delayed reduction of cholinesterase activity. It is recommended that poisoning with the granular form of disulfoton should be treated with repetitive or prolonged gastric and intestinal lavage, charcoal, and a continuous intravenous infusion of pralidoxime iodide in addition to atropine sulfate.
AuthorsK Futagami, K Otsubo, Y Nakao, T Aoyama, E Iimori, S Urakami, M Ide, R Oishi
JournalJournal of toxicology. Clinical toxicology (J Toxicol Clin Toxicol) Vol. 33 Issue 2 Pg. 151-5 ( 1995) ISSN: 0731-3810 [Print] United States
PMID7897754 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Cholinesterase Reactivators
  • Pralidoxime Compounds
  • Disulfoton
  • Cholinesterases
  • pralidoxime
Topics
  • Aged
  • Cholinesterase Reactivators (therapeutic use)
  • Cholinesterases (blood)
  • Disulfoton (metabolism, poisoning)
  • Erythrocytes (enzymology)
  • Female
  • Humans
  • Pralidoxime Compounds (therapeutic use)
  • Suicide, Attempted
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: